dactinomycin has been researched along with mesna in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (14.29) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Iqbal, Z; Mallick, JA; Zaidi, SH | 1 |
| Exner, U; Göbel, U; Jürgens, H; Kühl, J; Ritter, J; Treuner, J; Weinel, P; Winkler, K | 1 |
| Akatchereian, C; Flamant, F; Ghosn, M; Salloum, E; Taleb, N | 1 |
| Czyzewski, EA; Goldman, S; Hallahan, DE; Mundt, AJ; Nachman, J; Rubin, C | 1 |
| Gardner, RV; Shetty, AK; Warrier, RP; Yu, LC | 1 |
| Crooke, MJ; Delahunt, B; Lewis, ME; Pringle, KC; Wiltshire, EJ | 1 |
| Goto, T; Hozumi, T; Kobayashi, H; Kondo, T; Kosaku, H | 1 |
| Burger, CW; Ewing, P; Seynaeve, C; Snijders-Keilholz, A | 1 |
| Bisogno, G; Carli, M; Casanova, M; Ferrari, A; Meazza, C; Zanetti, I | 1 |
| El-Baz, M; Ghali, AM; Ghoneim, MA; Sarhan, MM; Sarhan, OM | 1 |
| Anderson, JR; Dasgupta, R; Gupta, AA; Hawkins, DS; Indelicato, DJ; Pappo, AS; Spunt, SL | 1 |
4 review(s) available for dactinomycin and mesna
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Soft tissue sarcoma: postoperative chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Administration Schedule; Humans; Ifosfamide; Melphalan; Mesna; Methotrexate; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2004 |
Primitive neuroectodermal tumor of the cervix uteri: a case report -- changing concepts in therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Mesna; Neoadjuvant Therapy; Neuroectodermal Tumors, Primitive, Peripheral; Uterine Cervical Neoplasms; Vincristine | 2005 |
Bilateral Wilms' tumors: single-center experience with 22 cases and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Egypt; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Mesna; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nephrectomy; Retrospective Studies; Treatment Outcome; Vincristine; Wilms Tumor | 2010 |
3 trial(s) available for dactinomycin and mesna
| Article | Year |
|---|---|
Ifosfamide in soft tissue sarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Mesna; Sarcoma; Soft Tissue Neoplasms | 1990 |
Role of chemotherapy in the treatment of infantile fibrosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fibrosarcoma; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Mesna; Soft Tissue Neoplasms; Vincristine | 1999 |
Full-dose ifosfamide can be safely administered to outpatients.
Topics: Adolescent; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dactinomycin; Dose-Response Relationship, Drug; Humans; Ifosfamide; Infant; Mesna; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Vincristine | 2008 |
7 other study(ies) available for dactinomycin and mesna
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine | 1989 |
Irreversible encephalopathy with ifosfamide/mesna.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Child, Preschool; Dactinomycin; Female; Humans; Ifosfamide; Maxillary Neoplasms; Mercaptoethanol; Mesna; Rhabdomyosarcoma; Vincristine | 1987 |
Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Feasibility Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Radiotherapy Dosage; Retrospective Studies; Salvage Therapy; Sarcoma; Treatment Failure; Vincristine; Whole-Body Irradiation | 1999 |
Serum creatine kinase levels parallel the clinical course for rhabdomyomatous Wilms tumor.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Creatine Kinase; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Infant; Kidney Neoplasms; Mesna; Neoplasm Recurrence, Local; Nephrectomy; Reference Standards; Rhabdomyoma; Vincristine; Wilms Tumor | 2001 |
Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Topics: Adolescent; Age Factors; Anemia; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Incidence; Male; Mesna; Neutropenia; Rhabdomyosarcoma; Sex Characteristics; Survival Rate; Thrombocytopenia; Vincristine; Young Adult | 2012 |